Milestone Pharmaceuticals (MIST) Common Equity (2018 - 2026)
Milestone Pharmaceuticals (MIST) posted Common Equity of $36.0 million for Q1 2026, down 13.69% on a QoQ basis from $41.8 million in Q4 2025, and up 688.75% year-over-year from $4.6 million in Q1 2025.
Milestone Pharmaceuticals (MIST) Common Equity (2018 - 2026) Analysis & Trends
Milestone Pharmaceuticals' Common Equity history runs 9 years deep, the most recent figure standing at $36.0 million for Q1 2026.
- Quarterly Common Equity rose 688.75% year-over-year to $36.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.0 million (up 688.75% YoY) and the FY2025 annual result came in at $41.8 million, up 217.71% from the prior year.
- Common Equity was $36.0 million for Q1 2026 at Milestone Pharmaceuticals, down from $41.8 million in the prior quarter.
- Across five years, Common Equity topped out at $100.8 million in Q1 2022 and bottomed at -$17.7 million in Q2 2025.
- A 5-year average of $38.5 million and a median of $36.0 million in 2026 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2025 — Common Equity sank 155.49% — and 2026, when it surged 688.75%.
- Milestone Pharmaceuticals' Common Equity stood at $66.3 million in 2022, then slumped by 74.72% to $16.8 million in 2023, then retreated by 21.61% to $13.1 million in 2024, then soared by 217.71% to $41.8 million in 2025, then dropped by 13.69% to $36.0 million in 2026.
- Business Quant data shows MIST's Common Equity at $36.0 million in Q1 2026, $41.8 million in Q4 2025, and $20.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - | 36.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.05 Mn |
| Dec 31, 2025 | 41.77 Mn |
| Sep 30, 2025 | 20.50 Mn |
| Jun 30, 2025 | -17.75 Mn |
| Mar 31, 2025 | -6.12 Mn |
| Dec 31, 2024 | 13.15 Mn |
| Sep 30, 2024 | 24.01 Mn |
| Jun 30, 2024 | 31.98 Mn |
| Mar 31, 2024 | 39.92 Mn |
| Dec 31, 2023 | 16.77 Mn |
| Sep 30, 2023 | 28.50 Mn |
| Jun 30, 2023 | 40.41 Mn |
| Mar 31, 2023 | 53.94 Mn |
| Dec 31, 2022 | 66.35 Mn |
| Sep 30, 2022 | 77.16 Mn |
| Jun 30, 2022 | 86.66 Mn |
| Mar 31, 2022 | 100.76 Mn |
| Dec 31, 2021 | 112.60 Mn |
| Sep 30, 2021 | 127.42 Mn |
| Jun 30, 2021 | 139.59 Mn |